Newsfeeds - Spark Newswire

3 minute read

The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug

By Vandana Singh

Today, 5:09 PM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ADCT

2 minute read

Kamada Announces $11.4M Agreement To Supply VARIZIG To An Undisclosed International Organization

By Bill Haddad

Today, 5:09 PM

Procurement Agreement Following a New Tender Won from an International Organization Operating Principally in Latin America Product Supply Expected During

EBS

1 minute read

U.S. FDA Accepts Emergent’s Anthrax Vaccine Candidate Filing For Review

By Ragothaman Srinivasan

Today, 5:09 PM

The U.S. Food and Drug Administration (FDA) has accepted to review Emergent BioSolutions’ (NYSE: EBS) Biologics License Application (BLA) for its new anthrax vaccine candidate AV7909. The regulatory agency sets the Prescription Drug User Fee Act (PDUFA) goal date for a decision in month of April 2023.

EBS

2 minute read

Emergent BioSolutions Announces FDA Acceptance Of Biologics License Application For AV7909 Anthrax Vaccine Candidate

By Benzinga Newsdesk

Today, 5:09 PM

Emergent BioSolutions Inc. (NYSE:EBS) announced today that the U.S. Food and Drug Administration (FDA) accepted for review the Biologics License Application (BLA) for AV7909 (Anthrax Vaccine Adsorbed, Adjuvanted). AV7909

EBS

1 minute read

Emergent BioSolutions Highlights Publication of CHIKV VLP Phase 2 Safety And Immunogenicity Data In The Lancet Infectious Diseases

By Bill Haddad

Today, 5:09 PM

Emergent BioSolutions Inc. (NYSE:EBS) announced today that two-year persistence data from its phase 2 clinical study evaluating the safety and immunogenicity of the company’s investigational chikungunya virus

EBS

6 minute read

Morning Brief: Top Financial Stories Dominating on Tuesday, June 7

By Akanksha Bakshi

Today, 5:09 PM

Reuters

AAPL

2 minute read

J&J Serves Notice To Emergent For Terminating COVID-19 Shot Contract As Two Accuse Each Other Of Breach Of Agreement

By Shanthi Rexaline

Today, 5:09 PM

Johnson & Johnson (NYSE: JNJ) has made another move towards severing its Covid-19 vaccine manufacturing ties with contract manufacturer Emergent Biosolutions, Inc. (NYSE: EBS).

EBS

1 minute read

Traders Circulate World Health Organization Speakers List For June 3; Cos Mentioned Are Emergent, SIGA Technologies

By Benzinga Newsdesk

Today, 5:09 PM

https://cdn.who.int/media/docs/default-source/blue-print/agenda_monkeypox-research-priorities_june2022_webversion13.pdf

EBS

1 minute read

Why Emergent Biosolutions Stock Is Rising Today

By Adam Eckert

Today, 5:09 PM

Emergent Biosolutions Inc (NYSE: EBS) shares are trading higher Monday amid increasing monkeypox concerns.

CMRX

3 minute read

38 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

Today, 5:09 PM

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia.

AFI